OAKLAND, Calif., May 20, 2021 -- Koya Medical (“Koya”), a medical technology company advancing evidence-based therapies for vascular disease, will present at the Oppenheimer MedTech, Tools & Diagnostics Summit on Wednesday, May 26, 2021. Koya Founder, CEO and President Andy Doraiswamy, Ph.D., will provide an overview of Koya's recent business milestones and developments with the company's product, Dayspring™, the first FDA-cleared, wearable and mobility-enabled compression system for the treatment of lymphedema and venous diseases. The Company's presentation will be available throughout the day on May 26 to all conference participants.
The Oppenheimer MedTech, Tools & Diagnostics Summit investor conference will be held virtually. Institutional investors who wish to schedule a meeting with Koya management can contact their Oppenheimer sales representative or Damian Rippole at damian@koyamedical.com.
About Koya Medical
Founded in 2018 and headquartered in Dallas, Koya Medical is a medical technology company developing a portfolio of evidence-based treatments designed to improve clinical outcomes and patient experience in vascular disease.
